Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma
- 16 May 2017
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 88 (20), 1889-1893
- https://doi.org/10.1212/wnl.0000000000003918
Abstract
Objective: To address whether to restart older patients on anticoagulants or antiplatelet agents in the setting of a chronic subdural hematoma (cSDH). Methods: This is an update of a previous review (searched until July 2012). Medline, EMBASE, ISI Web of Knowledge, Google Scholar, PLOS, and the Cochrane Register for Systematic Reviews databases were searched from January 2012 to December 2016. Studies included older adults (those over 65 years) experiencing traumatic subdural hematoma or cSDH who were on anticoagulation or antiplatelet agents. Results: Seven studies were included (mean age 72 years). Four out of 7 studies provided combined data on anticoagulants or antiplatelet use. Only one study found anticoagulant or antiplatelet agent use to be a significant factor for cSDH rebleeding. Two studies considered anticoagulant use only and both reported similar increased odds of rebleeding (odds ratio [OR] 1.75, 95% confidence interval [CI] 0.18–16.86; OR 2.7 95% CI 1.42–6.96). Antiplatelets were not found to be associated with rebleeding. Ideal timing to resume anticoagulants or antiplatelets was unclear. Conclusions: Anticoagulant medication was associated with increased rebleeding risk in older adults with cSDH. However, antiplatelet medication was not associated with increased risk of rebleeding.This publication has 33 references indexed in Scilit:
- Anticoagulation therapy a risk factor for the development of chronic subdural hematomaClinical Neurology and Neurosurgery, 2013
- Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the ElderlyPLOS ONE, 2013
- Neurological and functional outcomes of subdural hematoma evacuation in patients over 70 years of ageJournal of Neurosciences in Rural Practice, 2013
- Impact of Pre-Hospital Antithrombotic Medication on the Outcome of Chronic and Acute Subdural HematomaJournal of Neurological Surgery Part A: Central European Neurosurgery, 2013
- Independent predictors for recurrence of chronic subdural hematomaActa Neurochirurgica, 2012
- Safety of Early Warfarin Resumption following Burr Hole Drainage for Warfarin-Associated Subacute or Chronic Subdural HemorrhageJournal of Neurotrauma, 2012
- GRADE guidelines: 7. Rating the quality of evidence—inconsistencyJournal of Clinical Epidemiology, 2011
- Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort studyNeurosurgical Review, 2004